Ardent Health Financials - Benzinga

Ardent Health Inc

ARDTNYSE

Trade with Public

Trade with Public

$11.93

0.10.85%

Ult. Agg.: Oct 28, 4:46 PM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Ardent Health Financials

Ardent Health (ARDT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Ardent Health Lowers FY2026 GAAP EPS Guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.441B Est

Ardent Health (NYSE:ARDT) lowers FY2026 GAAP EPS guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs

Benzinga Newsdesk

PRO
Ardent Health Partners Q2 EPS $0.12 Misses $0.19 Estimate, Sales $1.622B Beat $1.590B Estimate

Ardent Health Partners (NYSE:ARDT) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.19 by 36.84 percent. This is a 76.92 percent decrease over earnings of $0.52 per share

Benzinga Newsdesk

PRO
Ardent Health Reaffirms FY26 Adj EBITDA Guidance Of $485M-$535M

Commenting on the Company's financial outlook, Alfred Lumsdaine, Chief Financial Officer, said "During the second quarter, we've observed volume softness across our portfolio. We have taken appropriate and decisive

Benzinga Newsdesk

PRO
Ardent Health Affirms FY2026 GAAP EPS Guidance of $0.90-$1.27 vs $1.13 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.567B Est

Ardent Health (NYSE:ARDT) affirms FY2026 GAAP EPS guidance from $0.90-$1.27 to $0.90-$1.27 vs $1.13 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs

Benzinga Newsdesk

PRO
Ardent Health Partners Q1 EPS $0.28 Beats $0.20 Estimate, Sales $1.601B Beat $1.582B Estimate

Ardent Health Partners (NYSE:ARDT) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.20 by 40 percent. This is a 3.45 percent decrease over earnings of $0.29 per share from

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights